TLR3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Strayer Strayer DR DR Carter Carter WA WA Stouch Stouch BC BC A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome PLoS One PLoS One 2012 2012 7 7 e31334 e31334 10.1371/journal.pone.0031334 10.1371/journal.pone.0031334 supplied-pmid 22431963?